SCHEMBL27971007

SCHEMBL27971007

CC(CCC(=O)O)c1ccc(Br)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
USP5 P45974 1/20 0.43
CYP1A2 P05177 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41
GABRE P78334 2/20 0.41
GABRA6 Q16445 2/20 0.41
GABRG1 Q8N1C3 2/20 0.41
GABRG3 Q99928 2/20 0.41
GABRQ Q9UN88 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1433579 0.83 ESR1 (0.50) USP5CYP1A2GABRPGABRDGABRA1
SCHEMBL13383477 0.83 ACHE (0.53) ALOX5USP5CYP1A2GABRPGABRD
SCHEMBL16527043 0.83 ACHE (0.53) ALOX5USP5CYP1A2GABRPGABRD
SCHEMBL16527237 0.83 ACHE (0.53) ALOX5USP5CYP1A2GABRPGABRD
SCHEMBL242853 0.82 RIPK1 (0.52) CYP1A2GABRPGABRDGABRA1GABRB1
SCHEMBL10042378 0.82 RIPK1 (0.52) CYP1A2GABRPGABRDGABRA1GABRB1
SCHEMBL8673121 0.82 RIPK1 (0.52) CYP1A2GABRPGABRDGABRA1GABRB1
SCHEMBL25173307 0.81 USP5 (0.43) ALOX5USP5CYP1A2SMN1; SMN2GABRP
SCHEMBL2692841 0.81 USP5 (0.47) ALOX5USP5CYP1A2SMN1; SMN2GABRP
SCHEMBL9081205 0.81 USP5 (0.47) USP5CYP1A2SMN1; SMN2FFAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104284899-A Tricyclic compounds and methods of use therefor HOFFMANN LA ROCHE 2015-01-14 CN disclosed